Promis Neurosciences Stock Piotroski F Score

PMN Stock  USD 1.01  0.04  4.12%   
This module uses fundamental data of ProMIS Neurosciences to approximate its Piotroski F score. ProMIS Neurosciences F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of ProMIS Neurosciences. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about ProMIS Neurosciences financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out ProMIS Neurosciences Altman Z Score, ProMIS Neurosciences Correlation, ProMIS Neurosciences Valuation, as well as analyze ProMIS Neurosciences Alpha and Beta and ProMIS Neurosciences Hype Analysis.
To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.
  
At this time, ProMIS Neurosciences' Short and Long Term Debt Total is very stable compared to the past year. As of the 11th of December 2024, Net Debt To EBITDA is likely to grow to 0.98, though Net Debt is likely to grow to (15.9 M). At this time, ProMIS Neurosciences' Average Payables is very stable compared to the past year. As of the 11th of December 2024, Interest Coverage is likely to grow to 98.53, while Price To Sales Ratio is likely to drop 5,071.
At this time, it appears that ProMIS Neurosciences' Piotroski F Score is Frail. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
2.0
Piotroski F Score - Frail
Current Return On Assets

Negative

Focus
Change in Return on Assets

Decreased

Focus
Cash Flow Return on Assets

Negative

Focus
Current Quality of Earnings (accrual)

Improving

Focus
Asset Turnover Growth

Decrease

Focus
Current Ratio Change

Decrease

Focus
Long Term Debt Over Assets Change

Lower Leverage

Focus
Change In Outstending Shares

Increase

Focus
Change in Gross Margin

No Change

Focus

ProMIS Neurosciences Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to ProMIS Neurosciences is to make sure ProMIS is not a subject of accounting manipulations and runs a healthy internal audit department. So, if ProMIS Neurosciences' auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if ProMIS Neurosciences' financial numbers are properly reported.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover4.0E-44.0E-4
Notably Down
Slightly volatile
Total Current Liabilities13 M12.4 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total649.7 K683.9 K
Notably Down
Slightly volatile
Total Assets18.9 M18 M
Sufficiently Up
Slightly volatile
Total Current Assets18.9 M18 M
Sufficiently Up
Slightly volatile

ProMIS Neurosciences F Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between ProMIS Neurosciences' different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards ProMIS Neurosciences in a much-optimized way.

About ProMIS Neurosciences Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

Common Stock Shares Outstanding

12.91 Million

At this time, ProMIS Neurosciences' Common Stock Shares Outstanding is very stable compared to the past year.

ProMIS Neurosciences Current Valuation Drivers

We derive many important indicators used in calculating different scores of ProMIS Neurosciences from analyzing ProMIS Neurosciences' financial statements. These drivers represent accounts that assess ProMIS Neurosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of ProMIS Neurosciences' important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap43.8M29.1M48.3M32.6M14.1M13.4M
Enterprise Value42.2M28.1M31.8M24.6M(2.6M)(2.4M)

About ProMIS Neurosciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ProMIS Neurosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ProMIS Neurosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ProMIS Neurosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with ProMIS Neurosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ProMIS Neurosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will appreciate offsetting losses from the drop in the long position's value.

Moving together with ProMIS Stock

  0.71VALN Valneva SE ADRPairCorr
  0.73ERNA Eterna TherapeuticsPairCorr

Moving against ProMIS Stock

  0.78BMY Bristol Myers SquibbPairCorr
  0.72GILD Gilead SciencesPairCorr
  0.7ESPR Esperion TherapeuticsPairCorr
  0.47FLGC Flora Growth CorpPairCorr
  0.47DNA Ginkgo Bioworks HoldingsPairCorr
The ability to find closely correlated positions to ProMIS Neurosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ProMIS Neurosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ProMIS Neurosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ProMIS Neurosciences to buy it.
The correlation of ProMIS Neurosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ProMIS Neurosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ProMIS Neurosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ProMIS Neurosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether ProMIS Neurosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ProMIS Neurosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Promis Neurosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Promis Neurosciences Stock:
Check out ProMIS Neurosciences Altman Z Score, ProMIS Neurosciences Correlation, ProMIS Neurosciences Valuation, as well as analyze ProMIS Neurosciences Alpha and Beta and ProMIS Neurosciences Hype Analysis.
To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProMIS Neurosciences. If investors know ProMIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProMIS Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.04
Revenue Per Share
0.001
Return On Assets
(4.81)
Return On Equity
(10.99)
The market value of ProMIS Neurosciences is measured differently than its book value, which is the value of ProMIS that is recorded on the company's balance sheet. Investors also form their own opinion of ProMIS Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is ProMIS Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProMIS Neurosciences' market value can be influenced by many factors that don't directly affect ProMIS Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProMIS Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProMIS Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProMIS Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.